Evidence map›Paper›PMID 28666028›Full record

ArticlePloS one2017

Regeneration of hyaline-like cartilage in situ with SOX9 stimulation of bone marrow-derived mesenchymal stem cells.

Xiaowei Zhang, Shili Wu, Ty Naccarato, Manan Prakash-Damani, Yuan Chou, Cong-Qiu Chu, Yong Zhu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Long-term durable repaired cartilage induced by SOX9International journal of medical sciences · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaowei ZhangDivision of Arthritis and Rheumatic Disease, Oregon Health & Science University, Portland, OR, United States of America.
Shili WuVivoScript, Inc, Costa Mesa, CA, United States of America.
Ty NaccaratoVivoScript, Inc, Costa Mesa, CA, United States of America.
Manan Prakash-DamaniVivoScript, Inc, Costa Mesa, CA, United States of America.
Yuan ChouDivision of Arthritis and Rheumatic Disease, Oregon Health & Science University, Portland, OR, United States of America.
Cong-Qiu ChuDivision of Arthritis and Rheumatic Disease, Oregon Health & Science University, Portland, OR, United States of America.ORCID http://orcid.org/0000-0002-5642-4625
Yong ZhuVivoScript, Inc, Costa Mesa, CA, United States of America.
Oregon Health & Science University · US

Funding

Regeneration of hyaline cartilage in situ with bone marrow mesenchymal stem cellsI01BX002858 · VA · PORTLAND VA MEDICAL CENTER · PI CHU, CONG-QIU · 2016 to 2020
–
BLRD VA I01 BX002858BLRD VA I01 BX005195
6 · The paper itself

Abstract

Microfracture, a common procedure for treatment of cartilage injury, induces fibrocartilage repair by recruiting bone marrow derived mesenchymal stem cells (MSC) to the site of cartilage injury. However, fibrocartilage is inferior biomechanically to hyaline cartilage. SRY-type high-mobility group box-9 (SOX9) is a master regulator of chondrogenesis by promoting proliferation and differentiation of MSC into chondrocytes. In this study we aimed to test the therapeutic potential of cell penetrating recombinant SOX9 protein in regeneration of hyaline cartilage in situ at the site of cartilage injury. We generated a recombinant SOX9 protein which was fused with super positively charged green fluorescence protein (GFP) (scSOX9) to facilitate cell penetration. scSOX9 was able to induce chondrogenesis of bone marrow derived MSC in vitro. In a rabbit cartilage injury model, scSOX9 in combination with microfracture significantly improved quality of repaired cartilage as shown by macroscopic appearance. Histological analysis revealed that the reparative tissue induced by microfracture with scSOX9 had features of hyaline cartilage; and collagen type II to type I ratio was similar to that in normal cartilage. This short term in vivo study demonstrated that when administered at the site of microfracture, scSOX9 was able to induce reparative tissue with features of hyaline cartilage.

Indexed as

RegenerationAnimalsBone Marrow CellsCell LineCell ProliferationHumansHyaline CartilageMesenchymal Stem CellsRabbitsReal-Time Polymerase Chain ReactionSOX9 Transcription FactorSOX9 protein, humanSOX9 Transcription Factor

Identifiers

PMID28666028
PMCPMC5493350
OpenAlexW2733026249

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.